Researchers developed a scalable platform for making human pluripotent stem cell-derived cortical organoids, with quality checks covering organoid production and single-cell RNA sequencing. In a 96-well format, the team achieved about 100% organoid formation across 64 cell lines, while adjusting growth factors improved pluripotency and cortical patterning.

The organoids had gene-activity profiles and low-stress signatures similar to those of the developing human cortex. In organoids carrying the MAPT V337M mutation, single-cell analysis identified early changes in the phosphatase regulators PPP2CA and ANP32A, as well as the prefoldin subunit PFDN6, in excitatory neurons before tau hyperphosphorylation and oligomerization were detected.